Oxaliplatin Immune-Induced Syndrome Occurs With Cumulative Administration and Rechallenge: Single Institution Series and Systematic Review Study-Reference-Cited by-同舟云学术

Oxaliplatin Immune-Induced Syndrome Occurs With Cumulative Administration and Rechallenge: Single Institution Series and Systematic Review Study

Published:2016-09 Issue:3 Volume:15 Page:213-221
ISSN:1533-0028
Container-title:Clinical Colorectal Cancer
language:en
Short-container-title:Clinical Colorectal Cancer

Author:

Bencardino Katia,Mauri Gianluca,Amatu Alessio,Tosi Federica,Bonazzina Erica,Palmeri Laura,Querques Marialuisa,Ravera Federica,Menegotto Alberto,Boiani Elisa,Sartore-Bianchi Andrea,Siena Salvatore

Publisher

Elsevier BV

Subject

Gastroenterology,Oncology

Reference66 articles.

1. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer;Andre;N Engl J Med,2004

2. Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer;de Gramont;J Clin Oncol,2000

3. Panitumumab-FOLFOX4 treatment and RAS mutations in colorectal cancer;Douillard;N Engl J Med,2013

4. Bevacizumab in combination with oxaliplatin, fluorouracil, and leucovorin (FOLFOX4) for previously treated metastatic colorectal cancer: results from the Eastern Cooperative Oncology Group Study E3200;Giantonio;J Clin Oncol,2007

5. Oxaliplatin-related thrombocytopenia;Jardim;Ann Oncol,2012

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Oxaliplatin-induced immune thrombocytopenia in a patient with pancreatic cancer;European Journal of Case Reports in Internal Medicine;2024-08-21

2. Chemotherapy re-use versus anti-angiogenic monotherapy as the third-line treatment of patients with metastatic colorectal cancer: a real-world cohort study;BMC Cancer;2024-03-05

3. Cytokine profiling, pretreatment with anakinra, and tolerance development in platinum-induced mixed hypersensitivity reactions;Annals of Allergy, Asthma & Immunology;2023-10

4. Case report: A rare case of acute hemolysis in advanced rectal cancer after XELOX and nivolumab treatment: analysis of drug-dependent antibodies;Frontiers in Medicine;2023-05-25

5. Chinese expert consensus on managing thrombocytopenia in patients with cancer and liver injury;Oncology and Translational Medicine;2023-02